Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP412015.RApdBlBNJlrVFNCCZ_ojPZrdy15QCfSuxfsxdSs1JPby0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP412015.RApdBlBNJlrVFNCCZ_ojPZrdy15QCfSuxfsxdSs1JPby0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP412015.RApdBlBNJlrVFNCCZ_ojPZrdy15QCfSuxfsxdSs1JPby0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP412015.RApdBlBNJlrVFNCCZ_ojPZrdy15QCfSuxfsxdSs1JPby0130_provenance.
- NP412015.RApdBlBNJlrVFNCCZ_ojPZrdy15QCfSuxfsxdSs1JPby0130_assertion description "[Given that GDM women with persistent IGT are at a high risk of developing T2DM, understanding how the nutrient-sensitive mammalian target of rapamycin/S6K1 pathway is chronically activated in GDM may lead to important therapies that could prevent the progression to T2DM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP412015.RApdBlBNJlrVFNCCZ_ojPZrdy15QCfSuxfsxdSs1JPby0130_provenance.
- NP412015.RApdBlBNJlrVFNCCZ_ojPZrdy15QCfSuxfsxdSs1JPby0130_assertion evidence source_evidence_literature NP412015.RApdBlBNJlrVFNCCZ_ojPZrdy15QCfSuxfsxdSs1JPby0130_provenance.
- NP412015.RApdBlBNJlrVFNCCZ_ojPZrdy15QCfSuxfsxdSs1JPby0130_assertion SIO_000772 21289241 NP412015.RApdBlBNJlrVFNCCZ_ojPZrdy15QCfSuxfsxdSs1JPby0130_provenance.
- NP412015.RApdBlBNJlrVFNCCZ_ojPZrdy15QCfSuxfsxdSs1JPby0130_assertion wasDerivedFrom befree-20150227 NP412015.RApdBlBNJlrVFNCCZ_ojPZrdy15QCfSuxfsxdSs1JPby0130_provenance.
- NP412015.RApdBlBNJlrVFNCCZ_ojPZrdy15QCfSuxfsxdSs1JPby0130_assertion wasGeneratedBy ECO_0000203 NP412015.RApdBlBNJlrVFNCCZ_ojPZrdy15QCfSuxfsxdSs1JPby0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP412015.RApdBlBNJlrVFNCCZ_ojPZrdy15QCfSuxfsxdSs1JPby0130_provenance.